NASP Has Had Enough of DIR Fees

CSIlinkedinmainSuzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, regularly publishes industry articles on LinkedIn. Visit the CSI LinkedIn page and read the full articles by clicking here.

A recent comment by PCMA’s CEO, Mark Merritt, prompted a shot across the bough on Direct and Indirect Remuneration Fees plaguing the industry right now.

NASP feels that  Merritt’s comment that DIR Fees “don’t harm the health industry in any way; They only help it, ‘is’ inaccurate and strongly feel that they do  unfortunately harm the health industry, particularly as it relates to the negative impact on specialty pharmacy providers.”

View Full Article
2018-09-26T13:58:02+00:00